Veronica Peotta Jacobsen

Veronica Peotta Jacobsen

Auto-generated profile, based on publicly available information

Veronica Peotta Jacobsen

The University of Iowa, Iowa City, IA, USA

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 November 2011 in Lipids in Health and Disease
Verified
Journal Article
Open access
PDF file
SMSilvana S Meyrelles
Silvana S Meyrelles
VPVeronica A Peotta
Veronica A Peotta
Thiago PereiraThiago Pereira
Thiago Pereira
EVElisardo Vasquez
Elisardo Vasquez
Since the early 1990s, several strains of genetically modified mice have been developed as models for experimental atherosclerosis. Among the available models, the apolipoprotein E-deficient (apoE-/-) mouse is of particular relevance because of its propensity to spontaneously develop hypercholesterolemia and atherosclerotic lesions that are similar to those found in humans, even when the mice are fed a chow diet. The main purpose of this review is to highlight the key achievements that have contributed to elucidating the mechanisms pertaining to vascular dysfunction in the apoE-/- mouse. First, we summarize lipoproteins and atherosclerosis phenotypes in the apoE-/- mouse, and then we briefly discuss controversial evidence relative to the influence of gender on the development of atherosclerosis in this murine model. Second, we discuss the main mechanisms underlying the endothelial dysfunction of conducting vessels and resistance vessels and examine how this vascular defect can be influenced by diet, aging and gender in the apoE-/- mouse.

7 May 2019 in Oxidative Medicine and Cellular Longevity
Verified
Journal Article
Open access
PDF file
Elisardo C VasquezElisardo C Vasquez
Elisardo C Vasquez
Thiago PereiraThiago Pereira
Thiago Pereira
VPVeronica A. Peotta
Veronica A. Peotta
MBMarcelo P. Baldo
Marcelo P. Baldo
Manuel Campos-ToimilManuel Campos-Toimil
Manuel Campos-Toimil
The gut microbiota, the ecosystem formed by a wide symbiotic community of nonpathogenic microorganisms that are present in the distal part of the human gut, plays a prominent role in the normal physiology of the organism. The gut microbiota’s imbalance, gut dysbiosis, is directly related to the origin of various processes of acute or chronic dysfunction in the host. Therefore, the ability to intervene in the gut microbiota is now emerging as a possible tactic for therapeutic intervention in various diseases. From this perspective, evidence is growing that a functional dietary intervention with probiotics, which maintain or restore beneficial bacteria of the digestive tract, represents a promising therapeutic strategy for interventions in cardiovascular diseases and also reduces the risk of their occurrence. In the present work, we review the importance of maintaining the balance of the intestinal microbiota to prevent or combat such processes as arterial hypertension or endothelial dysfunction, which underlie many cardiovascular disorders. We also review how the consumption of probiotics can improve autonomic control of cardiovascular function and provide beneficial effects in patients with heart failure. Among the known effects of probiotics is their ability to decrease the generation of reactive oxygen species and, therefore, reduce oxidative stress. Therefore, in this review, we specifically focus on this antioxidant capacity and its relationship with the beneficial cardiovascular effects described for probiotics.

1 January 2012 in Journal of Biomedical Science
Verified
Journal Article
Open access
PDF file
EVElisardo Vasquez
Elisardo Vasquez
VPVeronica A Peotta
Veronica A Peotta
AGAgata L Gava
Agata L Gava
Thiago PereiraThiago Pereira
Thiago Pereira
SMSilvana S Meyrelles
Silvana S Meyrelles
Cardiovascular death is frequently associated with atherosclerosis, a chronic multifactorial disease and a leading cause of death worldwide. Genetically engineered mouse models have proven useful for the study of the mechanisms underlying cardiovascular diseases. The apolipoprotein E-deficient mouse has been the most widely used animal model of atherosclerosis because it rapidly develops severe hypercholesterolemia and spontaneous atherosclerotic lesions similar to those observed in humans. In this review, we provide an overview of the cardiac and vascular phenotypes and discuss the interplay among nitric oxide, reactive oxygen species, aging and diet in the impairment of cardiovascular function in this mouse model.

11 December 2012 in Pediatric Research
Verified
Journal Article
Open access
PDF file
SHSarah E. Haskell
Sarah E. Haskell
GHGregory M. Hermann
Gregory M. Hermann
BRBenjamin E. Reinking
Benjamin E. Reinking
KVKenneth A. Volk
Kenneth A. Volk
VPVeronica A. Peotta
Veronica A. Peotta
ROBERT ROGHAIRROBERT ROGHAIR
ROBERT ROGHAIR
Background: Sertraline, a selective serotonin reuptake inhibitor (SSRI), is the most commonly prescribed therapy for maternal depression. Epidemiologic studies have linked SSRI exposure with decreased fetal growth, altered autonomic regulation, and cardiac malformations. We hypothesized that SSRI exposure decreases left-ventricular (LV) volumes and increases adult sympathetic nervous system activation, resulting in increased adult heart rates. Methods: C57BL/6 mice received saline or sertraline (5 or 15 mg/kg/day i.p.) on postnatal days 1–14. Adult phenotypes were assessed at 5 mo. Results: Sertraline-exposed mice had smaller LV internal diameters in diastole (control 4.0 ± 0.1 mm, SSRI 3.7 ± 0.1 mm, P < 0.05), decreased stroke volumes (control 46 ± 2.6 µl, SSRI 37 ± 2.3 µl, P < 0.05), higher heart rates (control 530 ± 13 beats per minute (bpm), SSRI 567 ± 6 bpm, P <0.05), and increased urinary excretion of noradrenaline (control 174 ± 29.4 ng/ml, SSRI 276 ± 35.1 ng/ml, P < 0.05). These changes were associated with increased cerebral serotonin transporter (5-HTT) expression. Conclusion: Neonatal sertraline exposure causes long-term changes in cardiac morphology and physiology. We speculate that early-life SSRI exposure impairs cardiomyocyte growth and central serotonin signaling, leading to a small left heart syndrome in adult mice.

9 December 2019 in Oxidative Medicine and Cellular Longevity
Verified
Journal Article
Open access
PDF file
Elisardo C VasquezElisardo C Vasquez
Elisardo C Vasquez
Thiago PereiraThiago Pereira
Thiago Pereira
Manuel Campos-ToimilManuel Campos-Toimil
Manuel Campos-Toimil
MBMarcelo P. Baldo
Marcelo P. Baldo
VPVeronica A. Peotta
Veronica A. Peotta

26 February 2026 in British Journal of Ophthalmology
Verified
Journal Article
Closed access
PDF file
Hyeck-Soo SonHyeck-Soo Son
Hyeck-Soo Son
AZAnthony Zeng
Anthony Zeng
VJVeronica Peotta Jacobsen
Veronica Peotta Jacobsen
GWGrant Welk
Grant Welk
ANAva Niknahad
Ava Niknahad
JDJefferson J Doyle
Jefferson J Doyle
Background Early-onset high myopia (eoHM) associates with multiple ocular and systemic disorders. This study evaluates the repertoire and relative prevalence of these disorders in a tertiary care setting, parses them by eoHM and other characteristics and evaluates the utility of diagnostic workup. Methods We performed a retrospective analysis of eoHM cases seen at two US eye centres from 2012 to 2022. eoHM was defined as a myopic refraction requiring glasses when ≤2 years of age and/or a refraction greater than −6D by 6 years of age. We reviewed the extent and outcome of workup, including ocular examination, imaging, electrophysiology, systemic evaluation and genetic testing. Result Of 407 patients with eoHM, 39% had an associated ocular disorder, 21% had a systemic disorder and 40% had apparently isolated eoHM (ie, no associated condition). Patients with associated disorders often reported typical presenting complaints but were more likely to be seen earlier in life, to possess severe, symmetric or very asymmetric eoHM and to display other stigmata of visual dysfunction. Patients with connective tissue disorders and select inherited retinal disorders had the most severe and symmetric eoHM compared with other conditions or isolated cases. Electroretinography and genetic testing were critical workup components. Conclusions eoHM frequently associates with a wide array of ocular and systemic disorders and may display distinct clinical characteristics depending on the associated condition. Awareness of the range of disorders that present with eoHM, key distinguishing characteristics, the role of timely and targeted workup and the importance of an accurate diagnosis are key considerations.